Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

LAURUS

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 51
  • 0 comments

FDA approve SACUBITRIL; VALSARTAN

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 46
  • 0 comments

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

ALLERGAN

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 63
  • 0 comments

FDA approve OXYBUTYNIN

Comment Full text

CHARTWELL RX

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 48
  • 0 comments

FDA approve AMOXAPINE

Comment Full text

WATSON LABS

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 55
  • 0 comments

FDA approve PREDNISONE

Comment Full text

CRYSTAL

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 48
  • 0 comments

FDA approve SACUBITRIL; VALSARTAN

Comment Full text

HIKMA

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 48
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text

ALEMBIC

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 51
  • 0 comments

FDA approve SACUBITRIL; VALSARTAN

Comment Full text

HIKMA

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 50
  • 0 comments

FDA approve PREDNISONE

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 50
  • 0 comments

FDA approve PREDNISONE

Comment Full text
  • Previous
  • 442
  • 443
  • 444
  • 445
  • 446
  • Next

Search

News categories

  • Technical Exchange News(14691)
  • Event(6229)
  • SEC News(392627)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239349)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin